Net Sales Margin: CEL-SCI Corporation (CVM)

Brandmark of cel-sci.com (CVM)

Multikine innovations for pre-operative immune activation increase patient survival rates, and the GURU.Markets system displays this chart, where the net product margin currently holds the status 0.00. Geopolitical instability and sanctions are hindering international drug registration, prolonging clinical trials. Currently, CEL-SCI Corporation (CVM) is completing the development stage, striving for final approval of its therapy.

CEL-SCI Corp. (CVM) - Company Sales Margin from 07/04/2022 to 11/19/2026

Analytical breakdowns and data insights for company CEL-SCI (CVM)

- market value and analyst target forecast:
Comprehensive company analysis:CEL-SCI Corporation
Flagship merchandise of cel-sci.com

Sales margin measures the share of net profit in every dollar of revenue, revealing the actual efficiency of cost management. For CEL-SCI Corporation (CVM), this metric will reflect the scaling effect during the transition to industrial production of immunotherapy drugs. An analysis of aggregate sales profitability allows for the separation of accounting adjustments from the operating result. The trend line confirms the business's ability to convert sales into capital. Stable growth of this indicator guarantees the long-term sustainability of assets.

Who CEL-SCI Corporation competes with

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin OSTX|Net Sales Margin Radiopharm Theranostics Ltd (RADX)|Net Sales Margin ARTV (Artiva Biotherapeutics)|Net Sales Margin Adlai Nortye Ltd. ANL|Veru Inc - Net Sales Margin|Company Sales Margin Tempest Therapeutics TPST|XLO: Net Sales Margin|Enochian BioSciences (RENB) - Net Sales Margin|Return on Sales by Net Profit MURA|Kairos Pharma Ltd - Net Profit Margin|Net Sales Margin OKUR|CytoMed Therapeutics Limited (GDTC) - Net Profitability Margin|Net Sales Margin CRIS (Curis, Inc.)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)